re: Ann: Change of Director's Interest No... You know something...

re: Ann: Change of Director's Interest No... You know something guys, you're both correct.

ALT needs to show momentum with trials in order to keep the heads up and bring the options to the black.

That will however be a temporary spike. What needs to happen is for them to secure one of the three (3) multi-national pharma prospects they are working with.

They know and we know that the next 3 months matter a lot.

If that doesn't happen then I suspect the future isn't as bright as we would hope for.

But it is only April, the options expire in September and they are well aware of the issue at hand.

The technology is sound, but they must prove that their sales model will bear fruit.

Otherwise the biggest losers will be the directors.

I stopped looking at my holding about 3 weeks ago.

Will take a keen interest when July comes around.

GLAH